Literature DB >> 8654669

MHC expression in nonlymphoid tissues of the developing embryo: strongest class I or class II expression in separate populations of potential antigen-presenting cells in the skin, lung, gut, and inter-organ connective tissue.

A Grabowska1, L A Lampson.   

Abstract

We define expression of major histocompatibility complex (MHC) antigens in the nonlymphoid tissues of the developing rat. Antibodies to class I heavy and light chains (b2-m), and to class II MHC proteins were used. Strongest MHC expression was by individual cells in the skin, lung, gut, and inter-organ connective tissue. The class I+ and class II+ cells were distinct populations, differing in morphology, distribution, and expression of macrophage-associated antigens. A nonimmunologic role for MHC proteins in development has been proposed. Yet the distributions and antigenic profiles lead us to emphasize immunologic functions that may be served by the early presence of MHC+ cells outside the forming lymphoid organs. Potential contributions to establishment of extrathymic or maternal/fetal tolerance are discussed. Localization of strongest MHC expression to individual connective tissue cells of the developing organs, rather than parenchymal cells, is of clinical relevance to transplantation of fetal tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8654669     DOI: 10.1016/0145-305x(95)00003-c

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  3 in total

1.  Identification of qPCR reference genes suitable for normalising gene expression in the developing mouse embryo.

Authors:  John C W Hildyard; Dominic J Wells; Richard J Piercy
Journal:  Wellcome Open Res       Date:  2022-09-21

2.  Robust ability of IFN-gamma to upregulate class II MHC antigen expression in tumor bearing rat brains.

Authors:  Tanya Dutta; Alexander Spence; Lois A Lampson
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

3.  Stemness Correlates Inversely with MHC Class I Expression in Pediatric Small Round Blue Cell Tumors.

Authors:  Linda Müller; Maik Kschischo; Christian Vokuhl; David Stahl; Ines Gütgemann
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.